
About
This tool helps healthcare providers visually explain pelvic floor exam results to patients. It allows for inputting POP-Q scores, displaying prolapse stages, and emailing patient-specific reports. The app visually supports prolapse diagnoses and offers animations for stress urinary incontinence treatments.
What's New in AUGS POP
1.3
March 13, 2017
This app has been updated by Apple to display the Apple Watch app icon.
User reviews
Developer apps
FAQ
What is AUGS POP-Q used for?
AUGS POP-Q is an interactive tool for qualified healthcare providers to visually demonstrate pelvic floor exam results, including POP-Q scores and prolapse stages, to patients. It aids in patient education before and after surgery.
Can AUGS POP-Q diagnose prolapse?
No, AUGS POP-Q is not a diagnostic tool. It is designed to visually support the type and stage of prolapse as diagnosed by a qualified healthcare provider.
What kind of information can be emailed from AUGS POP-Q?
Users can email patient-specific assessment reports directly from the application via the iPhone's mail app. These reports include the prolapse image, location of the defect, and stage of prolapse.
What types of prolapse are included in the image library?
The image library in AUGS POP-Q includes examples of uterine prolapse, vaginal vault prolapse, anterior wall prolapse (with and without uterus), and posterior wall prolapse (with and without uterus).
Does AUGS POP-Q offer information on stress urinary incontinence?
Yes, AUGS POP-Q includes animations demonstrating normal anatomy, stress urinary incontinence (SUI), and SUI treatment options such as slings and bulking agents.
What devices does AUGS POP-Q support?
AUGS POP-Q is supported on iPhone and iPod devices. It was last updated on March 13, 2017, with version 1.3.
What is the age rating for AUGS POP-Q?
AUGS POP-Q has an age rating of 17+, indicating it is intended for adult users and healthcare professionals.
Does AUGS POP-Q have ads?
No, AUGS POP-Q does not contain advertisements. It is a free application developed by the American Urogynecologic Society.




